Treatment with resveratrol attenuates sublesional bone loss in spinal cord‐injured rats. (1st October 2013)

• Record Type: Journal Article
• Authors: Wang, Hua‐Dong; Shi, Ya‐Min; Li, Li; Guo, Ji‐Dong; Zhang, Yu‐Peng; Hou, Shu‐Xun
• Is Part Of: British journal of pharmacology. Volume 170:Number 4(2013:Oct.)
• Page Start: 796
• Page End: 806
• Publication Date: 2013-10-01
• Subjects: Pharmacology -- Periodicals; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1111/bph.12301
• Languages: English
• ISSNs: 0007-1188

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="bph12301-sec-0001" sec-type="section"> <title>Background and Purpose</title> <p>Sublesional osteoporosis predisposes individuals with spinal cord injury (SCI) to an increased risk of low‐trauma fracture. The aim of the present work was to investigate the effect of treatment with resveratrol (RES) on sublesional bone loss in spinal cord‐injured rats.</p> </sec> <sec id="bph12301-sec-0002" sec-type="section"> <title>Experimental Approach</title> <p>Complete SCI was generated by surgical transaction of the cord at the T<sub>10–12</sub> level. Treatment with RES (400 mg·kg<sup>−1</sup> body mass per day<sup>−1</sup>, intragastrically) was initiated 12 h after the surgery for 10 days. Then, blood was collected and femurs and tibiae were removed for evaluation of the effects of RES on bone tissue after SCI.</p> </sec> <sec id="bph12301-sec-0003" sec-type="section"> <title>Key Results</title> <p>Treatment of SCI rats with RES prevented the reduction of bone mass including bone mineral content and bone mineral density in tibiae, preserved bone structure including trabecular bone volume fraction, trabecular number, and trabecular thickness in tibiae, and preserved mechanical strength including ultimate load, stiffness, and energy in femurs. Treatment of SCI rats with RES enhanced femoral total sulfhydryl content, reduced femoral malondialdehyde and IL‐6 mRNA levels. Treatment of SCI rats with RES suppressed the up‐regulation of mRNA levels of PPARγ, adipose‐specific fatty‐acid‐binding protein and lipoprotein lipase, and restored mRNA levels of Wnt1, low‐density lipoprotein‐related protein 5, Axin2, ctnnb1, insulin‐like growth factor 1 (IGF‐1) and receptor for IGF‐1 in femurs and tibiae.</p> </sec> <sec id="bph12301-sec-0004" sec-type="section"> <title>Conclusions and Implications</title> <p>Treatment with RES attenuated sublesional bone loss in spinal‐cord‐injured rats, associated with abating oxidative stress, attenuating inflammation, depressing PPARγ signalling, and restoring Wnt/β‐catenin and IGF‐1 signalling.</p> </sec> </abstract>